Table 5.

Correlations between BCVA at baseline, month 12 and month 18 with the NEI-VFQ 25 composite score and scores of the two subscales of the MacTSQ at the corresponding times

	NEI-VFQ 25 composite baseline	MacTSQ subscale 1 Month 1	MacTSQ subscale 2 Month 1
Baseline BCVA all eyes (N=110)	0.387**	0.009	0.153
Baseline BCVA SE better eye (N=35)	0.499**	0.199	0.205
Baseline BCVA SE worse eye (N=73)	0.360**	0.041	0.144
	NEI-VFQ 25 composite Month 12	MacTSQ subscale 1 Month 12	MacTSQ subscale 2 Month 12
Month 12 BCVA all eyes (N=100)	0.329**	0.065	0.027
Month 12 BCVA SE better eye (N=30)	0.496**	0.200	0.173
Month 12 BCVA SE worse eye (N=70)	0.297*	0.030	0.074
	NEI-VFQ 25 composite Month 18	MacTSQ subscale 1 Month 18	MacTSQ subscale 2 Month 18
Month 18 BCVA all eyes (N=98)	0.405**	0.144	0.000
Month 18 BCVA SE better eye (N=31)	0.548**	0.058	0.104
Month 18 BCVA SE worse eye (N=68)	0.350**	0.185	0.060

*Denotes significance at 0.01. Information provision and convenience and **Denotes significance at 0.001. Impact of treatment and satisfaction.

BCVA, best-corrected visual acuity; MacTSQ, Macular Disease Society Treatment Satisfaction Questionnaire; NEI-VFQ, National Eye Institute Visual Function Questionnaire; SE, study eye.